Giovanni Ristori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Survival, mortality, causes and places of death in a european huntington's disease prospective cohort	MOVEMENT DISORDERS CLINICAL PRACTICE	2017
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics	GENOME BIOLOGY AND EVOLUTION	2016
Clinical manifestations of intermediate allele carriers in Huntington disease	NEUROLOGY	2016
Progression of motor subtypes in Huntington’s disease. a 6-year follow-up study	JOURNAL OF NEUROLOGY	2016
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study	MULTIPLE SCLEROSIS	2016
Riluzole in patients with hereditary cerebellar ataxia. Authors' reply	LANCET NEUROLOGY	2016
Spinocerebellar ataxia type 3 in Italy. time to change mind	NEUROEPIDEMIOLOGY	2016
Vaccines in multiple sclerosis. The experience of BCG vaccination	DRUGS OF THE FUTURE	2016
Exploring the structural relationship between interviewer and self-rated affective symptoms in Huntington’s disease	THE JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES	2016
IFN-β and multiple sclerosis: From etiology to therapy and back	CYTOKINE & GROWTH FACTOR REVIEWS	2015
Twin studies in multiple sclerosis. A meta-estimation of heritability and environmentality	MULTIPLE SCLEROSIS	2015
Epstein-Barr virus genetic variants are associated with multiple sclerosis	NEUROLOGY	2015
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial	LANCET NEUROLOGY	2015
Association between vaccines and neuroinflammation. time, risks, and benefits	JAMA NEUROLOGY	2015
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy	PLOS ONE	2015
arsenical c-glucoside derivatives with promising antitumor activity	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY	2015
Subacute multicranial neuropathy revealing an early case of meningeal syphilis	NEUROLOGICAL SCIENCES	2015

Progetti di Ricerca

Circulating small nucleolar RNA in Huntington disease: reporter of a tipping point in disease development and potential biomarker to follow therapeutic approaches in early stages of disease
Peripheral biomarkers in prodromal and Huntington's disease progression: predictive potential and drug-screening approach for treatment repurposing